B. Palmer

发表

Treatment regimens and outcomes in severe and moderate haemophilia A in the UK: The THUNDER study

M. Scott, H. Xiang, D. Hart, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

The risk of variant Creutzfeldt‐Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products

A. Molesworth, M. Makris, O. Gill, 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011.

R. Liesner, D. Hart, B. Palmer, 2014, Blood.

Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia Database and Haemtrack patient reported data: an observational study

H. Xiang, B. Palmer, D. Stephensen, 2022, BMJ Open.

Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom.

R. Liesner, B. Palmer, P. Collins, 2011, Blood.

Prevalence of Haemarthrosis and Clinical Impact on The Musculoskeletal System in People With Haemophilia in The United Kingdom; Evaluation of UK National Haemophilia Database and Haemtrack Patient Reported Data.

H. Xiang, B. Palmer, D. Stephensen, 2020 .

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full‐length to B‐domain‐deleted factor VIII: a prospective cohort comparison

R. Liesner, D. Hart, B. Palmer, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

Treatment burden, haemostatic strategies and real world inhibitor screening practice in non‐severe haemophilia A

K. Khair, P. Batty, D. Hart, 2017, British journal of haematology.

P107 Prevalence of haemarthrosis and clinical impact on the musculoskeletal system in people with haemophilia in the United Kingdom: evaluation of UKHCDO and haemtrack patient reported data

G. Chapman, B. Palmer, D. Stephensen, 2020 .

Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A

K. Pasi, P. Batty, D. Hart, 2015, Thrombosis and Haemostasis.

The immunogenicity of ReFacto AF (moroctocog alfa AF‐CC) in previously untreated patients with haemophilia A in the United Kingdom

B. Palmer, C. Hay, E. Chalmers, 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update

M. Makris, R. Liesner, J. Motwani, 2021, Haemophilia : the official journal of the World Federation of Hemophilia.

Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies

P. Volkers, R. Ljung, E. Santagostino, 2019, Haemophilia : the official journal of the World Federation of Hemophilia.

Current practice and registration patterns among United Kingdom Haemophilia Centre Doctors’ Organisation centers for patients with unclassified bleeding disorders

K. Downes, B. Palmer, S. MacDonald, 2021, Journal of thrombosis and haemostasis : JTH.

Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow‐up from the UK Haemophilia Centre Doctors’ Organisation (UKHCDO)

H. Xiang, D. Hart, B. Palmer, 2023, Haemophilia : the official journal of the World Federation of Hemophilia.

A national survey of immunosuppression strategies for acquired haemophilia A

R. Liesner, P. Batty, D. Hart, 2015, Haemophilia.